3132 Organometallics, Vol. 15, No. 14, 1996
Bell et al.
C4); P(OR)3, δ 13.7 (s, CH3), 66.1 (d, J ) 6.6 Hz, OCH2), 32.4
and 18.9 (s, CH2). Anal. Calcd for C22H41Cl2O3OsP: C, 40.9;
H, 6.36. Found: C, 40.7; H, 6.14.
44 mg (65%). Mp: 158-170 °C. 1H NMR (CDCl3): p-cymene,
δ 1.11 (d, J ) 6.9 Hz, 6H, CHMe2), 2.10 (s, 3H, Me), 2.88 (sept,
J ) 6.9 Hz, 1H, CHMe2), 5.27 (d, J ) 5.7 Hz, 2H, MeC6H4-
CHMe2), 5.21 (d, J ) 5.7 Hz, 2H, MeC6H4CHMe2); PR3, δ 2.24
(d, J ) 10.4 Hz, 6H, P-Me), 7.40-7.28 (m, 5H, Ph). 13C{1H}
NMR (CDCl3): p-cymene, δ 22.3 (s, C7), 19.4 (s, C1), 31.2 (s,
C6), 102.4 and 87.7 (s, C2 and C5), 81.5 (d, 2.9 Hz, C3 or C4),
77.1 (d, 4.6 Hz, C3 or C4); PR3, δ 18.7 (d, J ) 42.7 Hz, P-Me),
139.1 (d, J ) 45.5 Hz, ipso C6H5), 130.0 (s, Ph), 129.7 (d, J )
7.9 Hz, Ph), 128.3 (d, J ) 9.3 Hz, Ph). Anal. Calcd for
Os(p -cym en e)Cl2P (OiP r )3 (10): Orange powder, yield 190
mg (85%). Mp: 113-121 °C. 1H NMR (CDCl3): p-cymene, δ
1.26 (d, J ) 6.9 Hz, 6H, CHMe2), 2.23 (s, 3H, Me), 2.87 (sept,
J ) 6.9 Hz, 1H, CHMe2), 5.61 (d, J ) 5.7 Hz, 2H, MeC6H4-
CHMe2), 5.46 (d, J ) 5.7 Hz, 2H, MeC6H4CHMe2); P(OR)3, δ
1.30 (d, J ) 6.4 Hz, 18H, CH3), 4.94 (m, J ) 6.4 Hz, 3H, OCH).
13C{1H} NMR (CDCl3): p-cymene, δ 22.3 (s, C7), 17.7 (s, C1),
30.2 (s, C6), 100.0 and 95.3 (s, C2 and C5), 80.6 (d, J ) 4.5
Hz, C3 or C4), 79.7 (d, J ) 6.3 Hz, C3 or C4); P(OR)3, δ 23.9
(d, J ) 3.8 Hz, CH3), 70.8 (d, J ) 7.0 Hz, OCH). Anal. Calcd
for C19H35Cl2O3OsP: C, 37.8; H, 5.80. Found: C, 37.9; H, 5.53.
Os(p -cym en e)Cl2P Me2P h (11): Orange powder, yield 180
mg (89%). Mp: 163-177 °C. 1H NMR (CDCl3): p-cymene, δ
1.12 (d, J ) 7.0 Hz, 6H, CHMe2), 1.96 (s, 3H, Me), 2.49 (sept,
J ) 7.0 Hz, 1H, CHMe2), 5.34 (d, J ) 5.1 Hz, 2H, MeC6H4-
CHMe2), 5.24 (d, J ) 5.1 Hz, 2H, MeC6H4CHMe2); PR3, δ 1.85
(d, J ) 10.7 Hz, 6H, P-Me), 7.45 (m, 3H, Ph), 7.07 (t, J ) 8.5
Hz, 2H, Ph). 13C{1H} NMR (CDCl3), p-cymene, δ 21.8 (s, C7),
17.2 (s, C1), 29.7 (s, C6), 98.2 and 86.6 (s, C2 and C5), 80.2 (d,
J ) 3.8 Hz, C3 or C4), 80.1 (d, J ) 4.5 Hz, C3 or C4); PR3, δ
11.4 (d, J ) 39.2 Hz, P-Me), 137.4 (d, J ) 49.0 Hz, ipso C6H5),
129.7, 129.1, and 128.1 (s, Ph). Anal. Calcd for C18H25Cl2-
OsP: C, 40.3; H, 4.69. Found: C, 40.6; H, 4.82.
C
18H25I2OsP: C, 30.2; H, 3.49. Found: C, 30.2; H, 3.58. MS:
m/z 718 [M+] (192Os).
Os(p -cym en e)I2P n Bu 3 (20): Red powder, yield 42 mg
(60%). Mp: 156-164 °C. 1H NMR (CDCl3): p-cymene, δ 1.28
(d, J ) 6.8 Hz, 6H, CHMe2), 2.38 (s, 3H, Me), 3.13 (sept, J )
6.8 Hz, 1H, CHMe2), 5.12 (m, 4H, MeC6H4CHMe2); PR3, δ 0.95
(t, J ) 7.0 Hz, 9H, Me), 1.30-1.50 (m, 12H, CH2), 2.23 (m,
6H, P-CH2). 13C{1H} NMR (CDCl3): p-cymene, δ 22.5 (s, C7),
19.6 (s, C1), 31.5 (s, C6), 102.4 and 86.9 (s, C2 and C5), 80.9
and 76.2 (s, C3 or C4); PR3, δ 13.7 (s, CH3), 29.1 (d, J ) 33.6
Hz, P-CH2), 26.7 and 24.3 (s, CH2). Anal. Calcd for C22H41I2-
OsP: C, 33.9; H, 5.26. Found: C, 33.6; H, 5.20. MS: m/z 782
[M+] (192Os).
Os(p -cym en e)I2P P h 2Me (21): Red powder, yield 45 mg
(64%). Mp: 183-193 °C. 1H NMR (CDCl3): p-cymene, δ 0.91
(d, J ) 6.8 Hz, 6H, CHMe2), 2.18 (s, 3H, Me), 2.81 (sept, J )
6.8 Hz, 1H, CHMe2), 5.50 (d, J ) 5.4 Hz, 2H, MeC6H4CHMe2),
5.37 (d, J ) 5.4 Hz, 2H, MeC6H4CHMe2); PR3, δ 2.57 (t, J )
10.0 Hz, 3H, P-Me), 7.41-7.37 (m, 10H, Ph). 13C{1H} NMR
(CDCl3): p-cymene, δ 21.9 (s, C7), 18.6 (s, C1), 31.0 (s, C6),
102.7 and 88.7 (s, C2 and C5), 81.7 (s, C3 or C4), 78.3 (d, 4.7
Hz, C3 or C4); PR3, δ 19.9 (d, J ) 44.4 Hz, P-Me), 136.8 (d, J
) 52.3 Hz, ipso C6H5), 133.3 (d, J ) 9.0 Hz, Ph), 130.2 (s, Ph),
127.9 (d, J ) 10.0 Hz, Ph). Anal. Calcd for C23H27I2OsP: C,
35.5; H, 3.47. Found: C, 35.8 H, 3.53. MS: m/z 780 [M+]
Os(p -cym en e)Cl2P P h 2Me (12): Orange-yellow powder,
yield 200 mg (89%). Mp: 169-170 °C. 1H NMR (CDCl3):
p-cymene, δ 0.92 (d, J ) 7.0 Hz, 6H, CHMe2), 1.98 (s, 3H, Me),
2.32 (sept, J ) 7.0 Hz, 1H, CHMe2), 5.45 (d, J ) 5.7 Hz, 2H,
MeC6H4CHMe2), 5.39 (d, J ) 5.7 Hz, 2H, MeC6H4CHMe2); PR3,
δ 1.96 (d, J ) 11.4 Hz, 3H, P-Me), 7.4-7.7 (m, 10H, Ph).
13C{1H} NMR (CDCl3): p-cymene, δ 21.7 (s, C7), 17.1 (s, C1),
29.6 (s, C6), 99.0 and 87.7 (s, C2 and C5), 80.7 and 77.9 (s, C3
and C4); PR3, δ 11.1 (d, J ) 39.6 Hz, P-Me), 134.7 (d, J )
52.0 Hz, ipso C6H5), 132.7, 130.3 and 128.0 (s, Ph). Anal.
Calcd for C23H27Cl2OsP: C, 46.4; H, 4.54. Found: C, 46.4; H,
4.46.
Os(p -cym en e)Cl2P P n Bu 3 (14): Orange powder, yield 196
mg (87%). Mp: 176-179 °C. 1H NMR (CDCl3): p-cymene, δ
1.29 (d, J ) 6.9 Hz, 6H, CHMe2), 2.22 (s, 3H, Me), 2.77 (sept,
J ) 6.9 Hz, 1H, CHMe2), 5.61 (d, J ) 5.6 Hz, 2H, MeC6H4-
CHMe2), 5.40 (d, J ) 5.6 Hz, 2H, MeC6H4CHMe2); PR3, δ 0.95
(t, J ) 6.9 Hz, 9H, CH3), 2.00 (m, 6H, P-CH2), 1.40 (m, 12H,
CH2). 13C{1H} NMR (CDCl3): p-cymene, δ 22.3 (s, C7), 17.8
(s, C1), 30.3 (s, C6), 97.6 and 86.2 (s, C2 and C5), 80.1 (d, 3.1
Hz, C3 or C4), 76.6 (d, 6.5 Hz, C3 or C4); PR3, δ 13.6 (s, CH3),
23.7 (d, J ) 32.9 Hz, P-CH2), 25.1 (d, J ) 12.7 Hz, CH2), 24.2
(d, J ) 3.1, CH2). Anal. Calcd for C22H41Cl2OsP: C, 44.2; H,
6.87. Found: C, 44.3; H, 6.67.
(
192Os).
Os(p -cym en e)I2P P h 3 (22): Red powder, yield 47 mg (62%).
Mp: 220-223 °C. 1H NMR (CDCl3): p-cymene, δ 1.25 (d, J )
6.9 Hz, 6H, CHMe2), 2.01 (s, 3H, Me), 3.33 (sept, J ) 6.9 Hz,
1H, CHMe2), 5.61 (d, J ) 5.8 Hz, 2H, MeC6H4CHMe2), 5.10
(d, J ) 5.6 Hz, 2H, MeC6H4CHMe2); PR3, δ 7.40-7.75 (m, 15H,
Ph). 13C{1H} NMR (CDCl3): p-cymene, δ 22.8 (s, C7), 18.6 (s,
C1), 31.7 (s, C6), 105.2 and 91.4 (s, C2 and C5), 81.9 and 80.3
(s, C3 and C4); PR3, δ 135.3 (d, J ) 53.8 Hz, ipso C6H5), 135.8
(d, J ) 9.0 Hz, Ph), 130.5 (s, Ph), 127.5 (d, J ) 10.1 Hz, Ph).
Anal. Calcd for C28H29I2OsP: C, 40.0; H, 3.45. Found: C, 40.6;
H, 3.52. MS: m/z 715 [M+ - I] (192Os).
Os(p -cym en e)I2P iP r 3 (23): Red powder, yield 35 mg (53%).
Mp: 151-163 °C. 1H NMR (CDCl3): p-cymene, δ 1.33 (d, J )
7.3 Hz, 6H, CHMe2), 2.41 (s, 3H, Me), 3.17 (sept, J ) 7.3 Hz,
1H, CHMe2), 5.83 (m , 4H, MeC6H4CHMe2); PR3, δ 1.35 (dd,
J (PH) ) 13.1 Hz, J (H,H) ) 7.4 Hz, 18H, CH3), 3.01 (m, 3H,
P-CH). 13C{1H} NMR (CDCl3): p-cymene, δ 23.1 (s, C7), 19.4
(s, C1), 31.6 (s, C6), 102.2 and 87.2 (s, C2 and C5), 81.6 and
76.1 (s, C3 and C4); PR3, δ 21.1 (s, Me), 28.9 (d, J ) 26.0 Hz,
P-CH). Anal. Calcd for C19H35I2OsP: C, 30.9; H, 4.74.
Found: C, 30.9; H, 4.00. MS: m/z 613 [M+ - I] (192Os).
Os(p -cym en e)I2P Cy3 (24): Red powder, yield 48 mg (62%).
Mp: 143-151 °C. 1H NMR (CDCl3): p-cymene, δ 1.33 (d, J )
6.9 Hz, 6H, CHMe2), 2.38 (s, 3H, Me), 3.19 (sept, J ) 6.9 Hz,
1H, CHMe2), 5.81 (m, 4H, J ) 5.9 Hz, MeC6H4CHMe2); PR3, δ
2.26 (m, 3H, P-CH), 2.20 (m, 6H, CH2), 1.81 (m, 12H, CH2),
1.40 (m, 12H, CH2). 13C{1H} NMR (CDCl3): p-cymene, δ 22.9
(s, C7), 19.3 (s, C1), 31.6 (s, C6), 102.4 and 87.0 (s, C2 and
C5), 81.7 and 75.9 (s, C3 and C4); PR3, δ 38.9 (d, J ) 24 Hz,
P-CH), 30.6 (s, CH2), 27.3 (d, J ) 9.6 Hz, CH2), 26.5 (s, CH2).
No satisfactory microanalysis was obtained.
Os(p -cym en e)Cl2P P iP r 3 (17): Orange powder, yield 150
mg (71%). Mp: 142-146 °C. 1H NMR (CDCl3): p-cymene, δ
1.34 (d, J ) 7.5 Hz, 6H, CHMe2), 2.21 (s, 3H, Me), 2.83 (sept,
J ) 7.5 Hz, 1H, CHMe2), 5.87 (d, J ) 5.5 Hz, 2H, MeC6H4-
CHMe2), 5.78 (d, J ) 5.5 Hz, 2H, MeC6H4CHMe2); PR3, δ 1.34
(dd, J (P,H) ) 12.9 Hz, J (H,H) ) 6.9 Hz, 18H, CH3), 2.83 (m,
3H, P-CH). 13C{1H} NMR (CDCl3): p-cymene, δ 23.0 (s, C7),
17.9 (s, C1), 30.7 (s, C6), 97.5 and 87.2 (s, C2 and C5), 79.9 (d,
3.0 Hz, C3 or C4), 76.7 (d, 3.0 Hz, C3 or C4); PR3, δ 20.1 (s,
CH3), 25.3 (d, J ) 25.0 Hz, P-CH). Anal. Calcd for C19H35
Cl2OsP: C, 41.1; H, 6.31. Found: C, 41.4; H, 6.17.
-
Complexes 19-24 were similarly prepared by halogen
exchange of the corresponding dichloride complex of III using
NaI, for which a representative example is given for the
PMe2Ph-substituted complex 19.
Os(p -cym en e)I2P Me2P h (19). The dichloride 11 (50 mg,
0.09 mmol) and NaI (300 mg, 2.0 mmol) were stirred in MeOH
(10 mL) overnight at room temperature. The solution was
evaporated, redissolved in CH2Cl2 (10 mL), and filtered
(Celite), and the volume of solvent was reduced to 2-3 mL.
Pentane (15 mL) was added to precipitate a red powder, which
was filtered out and washed with cold ether (5 mL). Yield:
Os(p -cym en e)HClP Me3 (25). Complex 1 (90 mg, 0.19
mmol) and Et3N (0.5 mL, 0.5 mmol) were stirred at 80 °C in
ethanol (20 mL) for 5 h. The cooled solution was filtered
(Celite) and the volume of solvent reduced to 2-3 mL. The
product was purified by column chromatography using neutral